PGFC
ELV icon

Peapack-Gladstone Financial Corp’s Elevance Health ELV Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Sell
6,316
-199
-3% -$73.8K 0.03% 333
2026
Q1 		$1.91M Sell
6,515
-147
-2% -$48.3K 0.02% 340
2025
Q4 		$2.33M Sell
6,662
-406
-6% -$137K 0.03% 326
2025
Q3 		$2.28M Sell
7,068
-975
-12% -$303K 0.03% 328
2025
Q2 		$3.13M Sell
8,043
-275
-3% -$111K 0.04% 276
2025
Q1 		$3.62M Sell
8,318
-1,107
-12% -$444K 0.05% 263
2024
Q4 		$3.48M Sell
9,425
-262
-3% -$110K 0.05% 257
2024
Q3 		$5.04M Sell
9,687
-434
-4% -$232K 0.07% 224
2024
Q2 		$5.48M Sell
10,121
-5
-0% -$2.64K 0.08% 200
2024
Q1 		$5.25M Sell
10,126
-587
-5% -$292K 0.08% 211
2023
Q4 		$5.05M Sell
10,713
-145
-1% -$67K 0.09% 208
2023
Q3 		$4.73M Sell
10,858
-17
-0.2% -$7.71K 0.09% 204
2023
Q2 		$4.83M Sell
10,875
-77
-0.7% -$35.5K 0.09% 209
2023
Q1 		$5.07M Hold
10,952
– – 0.1% 210
2022
Q4 		$5.62M Sell
10,952
-29
-0.3% -$14.7K 0.11% 196
2022
Q3 		$4.99M Buy
10,981
+285
+3% +$136K 0.1% 193
2022
Q2 		$5.16M Sell
10,696
-68
-0.6% -$33.6K 0.12% 179
2022
Q1 		$5.29M Sell
10,764
-110
-1% -$50.3K 0.1% 183
2021
Q4 		$5.04M Sell
10,874
-109
-1% -$45.9K 0.1% 196
2021
Q3 		$4.09M Sell
10,983
-399
-4% -$152K 0.08% 201
2021
Q2 		$4.35M Sell
11,382
-119
-1% -$45.5K 0.1% 174
2021
Q1 		$4.13M Buy
11,501
+9,354
+436% +$3.01M 0.11% 171
2020
Q4 		$689K Buy
2,147
+19
+0.9% +$5.83K 0.02% 281
2020
Q3 		$572K Sell
2,128
-2
-0.1% -$538 0.02% 272
2020
Q2 		$560K Sell
2,130
-126
-6% -$33.6K 0.02% 267
2020
Q1 		$512K Buy
2,256
+78
+4% +$21.3K 0.02% 267
2019
Q4 		$658K Sell
2,178
-877
-29% -$241K 0.03% 236
2019
Q3 		$734K Sell
3,055
-1,430
-32% -$392K 0.03% 226
2019
Q2 		$1.27M Buy
4,485
+2,178
+94% +$595K 0.05% 183
2019
Q1 		$662K Sell
2,307
-13
-0.6% -$3.76K 0.03% 226
2018
Q4 		$609K Buy
2,320
+68
+3% +$18.7K 0.03% 224
2018
Q3 		$617K Buy
2,252
+203
+10% +$52.7K 0.03% 225
2018
Q2 		$488K Buy
2,049
+16
+0.8% +$3.71K 0.03% 235
2018
Q1 		$447K Buy
2,033
+75
+4% +$17.6K 0.02% 242
2017
Q4 		$441K Buy
1,958
+8
+0.4% +$1.7K 0.02% 245
2017
Q3 		$370K Buy
1,950
+250
+15% +$47.6K 0.02% 258
2017
Q2 		$320K Hold
1,700
– – 0.02% 272
2017
Q1 		$281K Hold
1,700
– – 0.02% 282
2016
Q4 		$244K Hold
1,700
– – 0.02% 293
2016
Q3 		$213K Hold
1,700
– – 0.01% 310
2016
Q2 		$223K Hold
1,700
– – 0.02% 297
2016
Q1 		$236K Sell
1,700
-400
-19% -$53.5K 0.02% 289
2015
Q4 		$293K Hold
2,100
– – 0.02% 272
2015
Q3 		$294K Hold
2,100
– – 0.02% 263
2015
Q2 		$345K Hold
2,100
– – 0.02% 250
2015
Q1 		$324K Hold
2,100
– – 0.02% 268
2014
Q4 		$264K Buy
+2,100
New +$259K 0.02% 273

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Peapack-Gladstone Financial Corp's ELV Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp reduced its Elevance Health (ELV) stake by 3.1% in Q2 2026, selling an estimated $73.8K and leaving 6,316 shares worth $2.44M. The position accounts for 0.03% of the portfolio, ranked #333.

Peapack-Gladstone Financial Corp first reported a position in ELV in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.62M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 6,316 shares of Elevance Health worth $2.44M as of Q2 2026.
  • Peapack-Gladstone Financial Corp sold 199 Elevance Health shares in Q2 2026, an estimated $73.8K.
  • Elevance Health made up 0.03% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #333 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Elevance Health in Q4 2014 and has held it in 47 quarters since.
  • Peapack-Gladstone Financial Corp's Elevance Health position peaked at $5.62M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.